Purpose: to compare stroke evaluations recommended by retina specialists and neurologists for retinal artery occlusion (raO). Design: a cross-sectional survey. Methods: an anonymous survey was emailed to members of the american academy of neurology Stroke Section listserv and vitreoretinal specialists registered with the american academy of Ophthalmology. the survey was divided based on duration of symptoms before encounter: less than 12 hours, 24-48 hours, and more than 1 week. institutional review board approval was obtained before data collection. Results: Four hundred forty-eight surveys were completed (281 retinologists and 167 neurologists). Within 12 hours of raO, most neurologists (75%) pursue a hospital-based evaluation, whereas the majority of retinologists (82%) pursue outpatient workup (P < 0.0001). Most neurologists (92%) and retinologists (98%) pursue outpatient stroke workup if symptoms have been present for more than 7 days. Conclusions: neurologists pursue higher acuity care after raO, whereas most retinologists order outpatient evaluations. retina specialists should consider urgent stroke evaluation to mitigate stroke risk factors.
(1) imaging all stroke patients and (2) evaluating all ischemic stroke and tia patients for treatable conditions such as carotid stenosis and atrial fibrillation.
2 the aHa/aSa guidelines for stroke prevention emphasize the importance of blood pressure control, treatment of dyslipidemia, and initiation of antiplatelet therapy or anticoagulation.
2 according to the aHa/aSa, these recommendations apply to both raO and amaurosis patients.
T he american Heart association (aHa) and the american Stroke association (aSa) define retinal artery occlusion (raO) as an ischemic stroke and amaurosis fugax as a retinal transient ischemic attack (tia).
1,2 unfortunately, vision loss is a poorly recognized indicator of stroke by both the general public 3 and healthcare providers. 4 additionally, many raO patients initially present to eye clinics instead of emergency departments. 5 Significant advances have decreased morbidity and mortality related to strokes and tias, primarily attributable to early detection and intervention.
6 Consequently, ophthalmologists play a critical role in stroke evaluation, treatment, and prevention for raO patients. neither the american academy of Ophthalmology (aaO) nor the american academy of neurology (aan) has published recommendations for acute raO evaluation. However, the aHa/aSa recommend Ethical approval for this study was provided by the institutional review Board of the university of Minnesota, Minneapolis, Minnesota, uSa before data collection.
Between april and September 2013, a web-based, anonymous survey (www.surveymonkey.com) was emailed to approximately 1150 members of the aan Stroke Section listserv and 1438 medical and surgical vitreoretinal specialists with email addresses in the aaO member directory. Practice specialty was self-reported. the survey email was sent once.
the survey described a 52-year-old patient presenting with an embolic retinal artery occlusion and normal erythrocyte sedimentation rate and C-reactive protein (Fig. 1) . respondents were asked how they would evaluate the patient at 3 different time points after symptom onset: less than 12 hours, 24-48 hours, and more than 7 days.
univariate analysis was performed to examine the differences between neurologists and retina specialists using the 2-tailed Fisher exact test.
materials and methods
Until recently, the activation of stroke protocols for acute RAO and amaurosis fugax has not been emphasized in the ophthalmic literature. 5, 7 One study reported that, although the majority of neurologists and neuro-ophthalmologists refer acute central retinal artery occlusions (CRAOs) to the emergency room for immediate evaluation, most general ophthalmologists do not. 5, 7 Acute evaluation might mitigate risk of secondary stroke by identifying and managing risk factors. Despite the AHA/ASA recommendations, the urgency and extent of stroke evaluation after acute RAO is not standardized. The study herein compares the practice patterns of retinal specialists and neurologists for acute, embolic RAOs. retina specialists reported they did not diagnose a CRAO in the prior year. Two percent of retina specialists and 57% of neurologists reported they did not diagnose a BRAO in the past year. Practice patterns after diagnosis of embolic RAOs are listed in Table 1 .
Within 12 hours of embolic RAO, most neurologists (75%) pursue a hospital-based evaluation [defined as hospital admission or emergency room (ER) evaluation], whereas the majority of retina specialists (82%) pursue outpatient evaluation (P < 0.0001) (Fig. 1) . Of the retina specialists who pursue outpatient evaluation within 12 hours of embolic RAO, most (59%) refer the patient to primary care or outpatient neurology, whereas 41% order imaging studies themselves. Only 7% of respondents refer for intra-arterial tissue plasminogen activator (tPA) within 12 hours of embolic RAO. The majority (74%) of these tPA proponents were neurologists.
For embolic RAOs presenting within 24-48 hours of vision loss, neurologists continue to pursue hospital-based evaluation more often than retina specialists (46% vs 8%, respectively; P < 0.0001). The overwhelming majority of both neurologists and retina specialists pursue less urgent, outpatient evaluation if embolic RAO symptoms have been present for more than 7 days (92% and 98%, respectively).
Of the respondents who order their own outpatient stroke workup [carotid ultrasound and echocardiogram (ECHO)] for embolic RAO presenting within 48 hours of vision loss, 84% of neurologists and 24% of retinologists (P < 0.0001) also order magnetic resonance imaging (MRI) of the brain. In this study, we found that within 48 hours of embolic RAO, neurologists tend to pursue higher acuity care, whereas most retina specialists refer the patient for outpatient evaluation by another provider. We also found that the majority of retina specialists do not order an MRI for acute embolic RAO, though most neurologists do. This suggests that retina specialists do not treat RAO like an acute stroke. Our findings are consistent with the Atkins study that found neurologists and neuro-ophthalmologists are more likely to refer acute RAO patients for emergent stroke evaluation.
7 Both our study and the Atkins study suggest that physicians with formal neurology training, specifically stroke neurology in our study, are more likely to treat RAOs as an acute stroke.
Neurologists operate in the world of brain ischemia in which stroke and TIA are considered neurologic emergencies. The AHA and ASA consider RAO a form of ischemic stroke, 1 which requires prompt evaluation for secondary prevention of recurrent stroke.
3 This may explain the tendency of neurologists in our study to pursue more acute care for RAO.
The need for urgent evaluation and treatment of cerebral ischemia has been widely studied in an effort to mitigate the elevated risk of subsequent major stroke. 2, [8] [9] [10] [11] For example, the 90-day stroke risk after TIA is estimated to be 10%, with half of these strokes occurring within the first 2 days. 9,11,12 Same-day evaluation after ischemia reduces the 90-day risk of recurrent stroke (2.1% vs 10.3%), 12 and treatment by a stroke specialist also consistently lowers stroke recurrence.
13 This identification of a critical window of increased stroke risk alongside a push for early evaluation and management in the hours after cerebral ischemia have contributed to large improvements in secondary stroke prevention in recent years.
6
Retinal ischemia portends an increased stroke risk that accordingly merits high acuity care. A retrospective study in Taiwan found a 20% higher accumulated incidence of stroke in the first year after RAO with a risk of recurrent stroke nearly 10 times higher in the first month.
14 This was also demonstrated in a self-controlled case series that showed a relative incident rate ratio (IRR) for stroke of 21.5 [95% confidence interval (CI), 11.3-40.9] for 1-30 days after a CRAO. 15 This risk peaked within the first 1-7 days after a CRAO, with an IRR of 67.8 (95% CI, 35.0-131.6) that eventually declined to an IRR of 1.0 (95% CI, 0.5-2.3) at 181-365 days post-CRAO.
15
The role of neuroimaging after RAO is also not standardized across specialities. 16 We found that the majority of retina specialists do not order an MRI for acute embolic RAO, though most neurologists do. Previous studies have shown the importance of MRI in identifying concurrent brain ischemia in RAO patients. A retrospective study of 129 patients by Helenius et al found that 24% of patients with either monocular vision loss or RAO had an acute cerebral infarction on diffusion weighted imaging (DWI) within 7 days of vision loss. 16 The majority (65%) of these patients had multiple acute cerebral infarcts. 16 Of the patients with acute brain infarction, 62% had an urgently treatable etiology and were more likely to demonstrate cardioembolic disease or large vessel stenosis. 16 Two other recent retrospective studies by Lee et al and Lauda et al found a similarly startling co-occurrence of RAO and cerebral infarction on DWI (24% and 23%, respectively). [17] [18] The presence of DWI findings is a stronger predictor of 7-day risk of stroke than clinical findings in patients with TIA. 19 We acknowledge the inherent limitations of a multiplechoice survey, as the results rely on accurate self-reporting, and answer choices may lead the respondent to an ideal response, which may differ from their true practice patterns. Our small sample size and low survey response rate might also introduce selection bias, which could potentially make our results less generalizable. Additionally, more than one third of the responding neurologists had not diagnosed any patient with RAO, and our sample size was not large enough to examine whether practice patterns are affected by experience.
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In conclusion, the majority of neurologists treat acute RAO with the same urgency as acute cerebral infarction, whereas most retina specialists pursue nonurgent outpatient evaluation. Retina specialists should consider a more urgent approach given the potential benefits. 
